Effects of IMT ON Dyspnea, PF and Quality of Life in Patients With CABG

Exercise Clinical Trial

Official title:

Effects of IMT ON Dyspnea, PF and Quality of Life in Patients With CABG

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT05936879
• Other study ID #: REC/RCR & AHS/23/0308
• Status: Completed
• Phase: N/A
• Start date: June 15, 2023
• Est. completion date: November 20, 2023

Study information

• Verified date: June 2024
• Source: Riphah International University
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

Patient in the Intervention group will be treated with routine pysical therapy, Inspiratory muscle training and early ambulation after surgery, whereas patients in the control group will be not be treated with these interventions and will rather undergo routine physical therapy (ankle pumps, hand pumps isometrics of upper and lower limbs).

Patients in the intervention group will receive treatment until discharge from hospital.

Description:

A randomized control trial in which two groups one is intervention and the other is controlled group .Patient in the Intervention group will be treated with routine pysical therapy, Inspiratory muscle training and early ambulation after surgery, whereas patients in the control group will be not be treated with these interventions and will rather undergo routine physical therapy (ankle pumps, hand pumps isometrics of upper and lower limbs).

Patients in the intervention group will receive treatment until discharge from hospital. On the day of discharge they will be assessed using 6 minute walk test, Borg rate of perceive exertion and health related quality of life scale. Data will be analyzed using SPSS 25.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 46
• Est. completion date: November 20, 2023
• Est. primary completion date: August 15, 2023
• Accepts healthy volunteers: No
• Gender: All
• Age group: 35 Years to 55 Years

Eligibility

Inclusion Criteria:

• Both Gender patients

• Patients who agreed to participate

• Age: 35 to 55

Exclusion Criteria:

• Patients with history of Angioplasty or CABG

• Chronic Renal failure

• Cardiac arrhythmias

• History of stroke

• Unstable angina

Related Conditions & MeSH terms

• Dyspnea
• Exercise

Intervention

Other:
• Inspiratory muscle training
Group A: Intervention group will be treated with Inspiratory muscle training and early ambulation and routine physical therapy including ankle pumps,hand pumps isometrics of upper and lower limbs after surgery
• physical therapy including ankle pumps, hand pumps isometrics of upper and lower limbs.
Group B: Control group routine physical therapy including ankle pumps, hand pumps isometrics of upper and lower limbs

Locations

Country	Name	City	State
Pakistan	National hospital Lahore.	Lahore	Punjab

Sponsors (1)

Lead Sponsor	Collaborator
Riphah International University

Country where clinical trial is conducted

Pakistan, 

References & Publications (4)

Caso G, Vosswinkel JA, Garlick PJ, Barry MK, Bilfinger TV, McNurlan MA. Altered protein metabolism following coronary artery bypass graft (CABG) surgery. Clin Sci (Lond). 2008 Feb;114(4):339-46. doi: 10.1042/CS20070278. — View Citation

Oliveira EK, Silva VZ, Turquetto AL. Relationship on walk test and pulmonary function tests with the length of hospitalization in cardiac surgery patients. Rev Bras Cir Cardiovasc. 2009 Oct-Dec;24(4):478-84. doi: 10.1590/s0102-76382009000500008. English, Portuguese. — View Citation

Pinheiro AR, Christofoletti G. Motor physical therapy in hospitalized patients in an intensive care unit: a systematic review. Rev Bras Ter Intensiva. 2012 Jun;24(2):188-96. English, Portuguese. — View Citation

Shakouri SK, Salekzamani Y, Taghizadieh A, Sabbagh-Jadid H, Soleymani J, Sahebi L, Sahebi R. Effect of respiratory rehabilitation before open cardiac surgery on respiratory function: a randomized clinical trial. J Cardiovasc Thorac Res. 2015;7(1):13-7. doi: 10.15171/jcvtr.2015.03. Epub 2015 Mar 29. — View Citation

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	6 Min walk test	The 6 min walk test is a sub-maximal exercise test used to assess aerobic capacity and endurance.It is also use to monitor your response to treatments for heart lung and other health problems.Provides a measure for integrated global response of multiple cardiopulmonary and musculoskeletal systems involved in exercise.	4 weeks
Secondary	Spirometer:	A spirometer is used to measure pulmonary function test including FVC, FEV1 and FEV1/FVC ratio. The normal values of FEV1/FVC ratio are >0.70 and FVC, FEV1 are >80% of predicted age	4 weeks